Global Autism Spectrum Disorder Diagnostics Market Share Analysis 2024, Forecast To 2033
22 Aug, 2024
The autism spectrum disorder diagnosis market size has grown significantly, increasing from $25.54 billion in 2023 to $27.39 billion in 2024, with a CAGR of 7.2%. This growth is due to heightened ASD awareness, expanded diagnostic criteria, advancements in diagnostic tools, improved healthcare systems, and public health campaigns. Looking ahead, the market is projected to grow to $36.35 billion in 2028 at a CAGR of 7.3%, driven by the rising prevalence of autism, growing awareness, early screening programs, and a focus on precision medicine and biomarkers. Key trends include the development of innovative technologies, an increasing focus on adult diagnosis, the demand for point-of-care testing, AI and machine learning integration, and increased research activities.
Global Autism Spectrum Disorder Diagnostics Market Key Driver
The growth in specialized diagnostic centers is expected to enhance the autism spectrum disorders diagnostic market. These centers, staffed with experts, conduct comprehensive evaluations to diagnose autism spectrum disorder, driven by advancements in diagnostics, demand for comprehensive care, professional training, and research. For example, Autism Speaks reported that the number of autism care network sites increased from 20 to 25 between 2021 and 2022 in North America. Consequently, the expansion of specialized diagnostic centers is supporting the growth of the autism spectrum disorders diagnostic market.
Get A Free Sample Of The Autism Spectrum Disorder Diagnostics Market ReportGlobal Autism Spectrum Disorder Diagnostics Market Segments
The autism spectrum disorder diagnostics market covered in this report is segmented –
1) By Type: Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder (PDD), Other Types
2) By Service: Behavioral Approaches, Early Intervention, Medication, Other Services
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies
By Geography:The regions covered in the autism spectrum disorder diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2023.
Major Autism Spectrum Disorder Diagnostics Industry Players
F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Siemens Healthineers, Quest Diagnostics Incorporated, Agilent Technologies Inc., Otsuka Pharmaceutical Co. Ltd., ARUP Laboratories, Invitae Corporation, Ambry Genetics, Cortica Inc., GeneDx, Cognoa Inc., Axial Therapeutics Inc., Curemark, EarliTec Diagnostics Inc., Yamo Pharmaceuticals
Purchase The Global Autism Spectrum Disorder Diagnostics Market Report Directly And Get A Swift DeliveryAutism Spectrum Disorder Diagnostics Market Overview
Autism spectrum disorder (ASD) diagnostics refer to the range of methods and tools used to identify and assess individuals suspected of having autism spectrum disorder. The goal of ASD diagnostics is to accurately identify the presence and severity of ASD symptoms, facilitate early intervention, and guide personalized treatment plans. These assessments are conducted by healthcare professionals specializing in neurodevelopmental disorders and are crucial for providing timely support and services to individuals on the autism spectrum and their families.
Autism Spectrum Disorder Diagnostics Global Market Report 2023 provides data on the global autism spectrum disorder diagnostics market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The autism spectrum disorder diagnostics market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.